logo-loader
RNS
viewSativa Group PLC

Sativa Group PLC - Goodbody Botanicals WH Smith Travel listing

RNS Number : 5807D
Sativa Group PLC
20 February 2020
 

Press Release

 

 

20 February 2020

 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

Sativa Group Plc

 

("Sativa" or "the Company" or "the Group")

 

Goodbody Botanicals secures significant product listing with WH Smith Travel

 

Sativa Group Plc subsidiary, Goodbody Botanicals, has secured a CBD product listing agreement with WH Smith Travel Ltd ("WHS Travel") which operates more than 550 UK convenience retail outlets with a concentration on travel hubs including airports, train stations, service stations and hospitals.  WHS Travel will stock Goodbody Botanical's products in circa 100 of their highest footfall UK stores. 

 

The WHS Travel product listing has resulted through Goodbody Botanicals' brand partnership agreement with SHS Sales & Marketing (GB) Limited ("SHS"), through which it is targeting key high-street retailers, grocers, and pharmacies.  This product listing is the first completed agreement of numerous other potential national product listing arrangements currently in discussion via SHS. 

 

Sativa Chief Executive Henry Lees-Buckley said: "Our new product listing with WHS Travel is a significant accomplishment for our Goodbody Botanicals brand, putting it in front a large number of consumers looking for a high-quality CBD brand they can trust". 

 

-     Ends -



 

 

 

Media enquiries. 

Abchurch Communications

Julian Bosdet

+44 (0)207 4594 4070 

+44 (0) 7771 663 886 

[email protected]

www.abchurch-group.com

 

 

For further information please contact: 

 

Henry Lees-Buckley 

Chief Executive Officer

Sativa Group Plc 

+44 (0) 20 7971 1255

 

[email protected]

www.sativagroup.co.uk

Joseph Colliver

Chief Financial Officer

Sativa Group Plc 

+44 (0) 20 7971 1255

 

[email protected] 

www.sativagroup.co.uk

NEX Exchange Corporate Adviser

 

Corporate Finance 

Stephen Keys / Max Gould 

Cenkos Securities plc 

+44 (0) 20 7397 8900

 

 

Equity Sales 

Julian Morse

Cenkos Securities

+44 (0) 20 7397 8900

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NEXURSNRRNUUURR

Quick facts: Sativa Group PLC

Price: 2.35

Market: AQSE
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Sativa Investments PLC acquires UK-based PhytoVista Laboratories

Geremy Thomas, chief executive of Sativa Investments PLC (AQSE:SATI), tells Proactive's Andrew Scott they've agreed to buy PhytoVista Laboratories, a UK-based lab that tests cannabis oils and hemp products, for £435,000. The British medicinal cannabis investment vehicle will pay £235,000...

on 4/7/18